NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE245905 Query DataSets for GSE245905
Status Public on Feb 04, 2024
Title Identification of TREM1+CD163+ myeloid cells as a deleterious immune subset in HCC [bulk_RNA-seq]
Organism Homo sapiens
Experiment type Expression profiling by high throughput sequencing
Summary Hepatocellular carcinoma (HCC) is an inflammation-associated cancer arising from viral and non-viral etiologies. Expansion of suppressive myeloid cells is a hallmark of chronic inflammation and cancer, but their heterogeneity in HCC is not fully resolved and might underlie immunotherapy resistance in the steatohepatitis setting. Here, we present a high resolution atlas of hepatic innate immune cells from patients with HCC that unravels a steatohepatitis contexture characterized by influx of inflammatory and immunosuppressive myeloid cells. A discrete myeloid cell population identified by selective expression of TREM1 and CD163 expands in steatohepatitis-HCC. We refer to this population as TREM1+ regulatory myeloid cells (Mreg), as it potently suppresses T cell effector functions, highly expresses TGFB1 and IL13RA1 and localizes to HCC fibrotic lesions.
 
Overall design Single-cell RNA-seq (10x Genomics) on FACS-sorted CD45 + panTCRαβ - CD19 - innate immune cells freshly isolated from tumors (HCC) and adjacent non-tumoral (NT) liver sections were realized for 10 patients (10 HCC/CHC samples and 10 NT/TS samples). In parallel, we applied spatial transcriptomics (ST; Visium ® , 10x Genomics) on frozen tissue sections from the two of the previous patients (2 CHC visium samples). Furthermore, bulk RNA-seq sequencing were performed on innate immunity cells that were isolated using the same sorting strategy designed for scRNAseq experiments, for six of the previous patients. Bulk RNA-seq sequencing were also realized on FACS-sorted cell population, namely THBS1_M (c0, c3 and c4) populations that were isolated according to specific sorting strategy. In summary, available data concerns 20 scRNA-seq samples, 2 visium spatial transcriptomics and 9 bulk RNA-seq.
 
Contributor(s) Giraud J, Chalopin D, Ramel E, Boyer T, Zouine A, Derieppe M, Larmonier N, Adotevi O, Le Bail B, Blanc J, Laurent C, Chiche L, Derive M, Nikolski M, Saleh M
Citation(s) 38350444
Submission date Oct 20, 2023
Last update date May 12, 2024
Contact name Maya Saleh
E-mail(s) maya.saleh@inrs.ca
Organization name INRS
Department Armand Frappier Santé Biotechnologie
Street address 531 Boulevard des Prairies
City Laval
State/province Qc
ZIP/Postal code H7V 1B7
Country Canada
 
Platforms (1)
GPL24676 Illumina NovaSeq 6000 (Homo sapiens)
Samples (9)
GSM7850784 innateCHC17, innate from patient 17
GSM7850785 innateCHC18, innate from patient 18
GSM7850786 innateCHC19, innate from patient 19
This SubSeries is part of SuperSeries:
GSE245909 Identification of TREM1+CD163+ myeloid cells as a deleterious immune subset in HCC
Relations
BioProject PRJNA1030367

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE245905_cpm_counts_RNAseq_matrix.tsv.gz 1.1 Mb (ftp)(http) TSV
GSE245905_raw_counts_RNASeq_matrix.txt.gz 672.2 Kb (ftp)(http) TXT
SRA Run SelectorHelp
Raw data are available in SRA

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap